logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Transplantation Of Liver

    Medications for Transplantation Of Liver

    FiltersReset Filters
    7 results

    • cellcept

      (Mycophenolate Mofetil)
      Genentech, Inc.
      Usage: CELLCEPT (mycophenolate mofetil) is indicated for the prevention of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, used alongside other immunosuppressive agents.

    • cyclosporine

      (CYCLOSPORINE)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Cyclosporine capsules (modified) are indicated for preventing organ rejection in kidney, liver, and heart transplants. They also treat severe rheumatoid arthritis inadequately responding to methotrexate and manage severe, recalcitrant plaque psoriasis in nonimmunocompromised adults who have not responded to other systemic therapies.

    • mycophenolate mofetil

      (MYCOPHENOLATE MOFETIL)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Mycophenolate mofetil (MMF) is indicated for the prevention of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, used in combination with other immunosuppressants.

    • mycophenolate mofetil

      (Mycophenolate Mofetil hydrochloride)
      BPI Labs LLC
      Usage: Mycophenolate Mofetil is indicated for preventing organ rejection in adult and pediatric patients (3 months and older) who have received allogeneic kidney, heart, or liver transplants, and is used in combination with other immunosuppressants.

    • neoral

      (cyclosporine)
      Novartis Pharmaceuticals Corporation
      Usage: Neoral is indicated for the prophylaxis of organ rejection in kidney, liver, and heart transplants, treatment of severe active rheumatoid arthritis unresponsive to methotrexate, and treatment of severe plaque psoriasis in adults who have not responded to other systemic therapies.

    • tacrolimus

      (Tacrolimus)
      Ascend Laboratories, LLC
      Usage: Tacrolimus capsules are indicated for the prophylaxis of organ rejection in adult patients undergoing allogeneic kidney, liver, or heart transplants, as well as in pediatric patients receiving allogeneic liver transplants, used in combination with other immunosuppressants.

    • tacrolimus

      (Tacrolimus)
      Sandoz Inc
      Usage: Tacrolimus capsules are indicated for the prevention of organ rejection in adult patients following allogeneic kidney, liver, or heart transplants, and in pediatric patients receiving allogeneic liver transplants, used in combination with other immunosuppressants.